Details of the Drug

General Information of Drug (ID: DMYD4PC)

Drug Name
N-(4-Phenyl-pyridin-2-yl)-guanidine
Synonyms CHEMBL54467; N-(4-Phenyl-pyridin-2-yl)-guanidine; Guanidine, N-(4-phenyl-2-pyridinyl)-; 2-(4-Phenyl-2-pyridinyl)guanidine; BDBM50108355
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 212.25
Logarithm of the Partition Coefficient (xlogp) 1.3
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C12H12N4
IUPAC Name
2-(4-phenylpyridin-2-yl)guanidine
Canonical SMILES
C1=CC=C(C=C1)C2=CC(=NC=C2)N=C(N)N
InChI
InChI=1S/C12H12N4/c13-12(14)16-11-8-10(6-7-15-11)9-4-2-1-3-5-9/h1-8H,(H4,13,14,15,16)
InChIKey
LQYVUDQYWIIZAV-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
10219978
ChEBI ID
CHEMBL54467
TTD ID
D07PSW
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tissue-type plasminogen activator (PLAT) TTXAGYU TPA_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-Pyridinylguanidines. Bioorg Med Chem Lett. 2002 Jan 21;12(2):181-4.